Current Edition

news

Sanofi adopts TriNetX platform to speed clinical trials

TriNetX has announced that it will be assisting Sanofi by using patient EHRs to optimize recruitment, streamline trial investigators’ workflows and otherwise impact t...
Continue Reading →
news

BioProtect Launches an International Multi-Center Clinical Study Following FDA investigational Device Exemption (IDE)

FDA has granted investigational Device Exemption approval (IDE) to conduct a pivotal clinical study examining theuse of the ProSpace[TM] Balloon System to prevent r...
Continue Reading →
news

FDA lifts clinical hold on fitusiran

Sanofi Genzyme, the specialty care global business unit of Sanofi, and Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced ...
Continue Reading →